Publication | Open Access
Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation
114
Citations
44
References
2007
Year
Cmv-specific CellsCytomegalovirus InfectionGambian InfantsCd8 T-cell PopulationPathogenesisImmunologyAntiviral ResponsePathologyVirologyAutoimmunityCd8 T-cell DifferentiationCd4 T Cell ResponsesChronic Viral InfectionMedicineViral ImmunityImmunological MemoryCmv-infected Infants
Cytomegalovirus (CMV) infection is endemic in Gambian infants, with 62% infected by 3 months and 85% by 12 months of age. We studied the CD8 T-cell responses of infants to CMV following primary infection. CMV-specific CD8 T cells, identified with tetramers, showed a fully differentiated phenotype (CD28(-) CD62L(-) CD95(+) perforin(+) granzyme A(+) Bcl-2(low)). Strikingly, the overall CD8 T-cell population developed a similar phenotype following CMV infection, which persisted for at least 12 months. In contrast, primary infection was accompanied by up-regulation of markers of activation (CD45R0 and HLA-D) on both CMV-specific cells and the overall CD8 T-cell population and division (Ki-67) of specific cells, but neither pattern persisted. At 12 months of age, the CD8 T-cell population of CMV-infected infants was more differentiated than that of uninfected infants. Although the subpopulation of CMV-specific cells remained constant, the CMV peptide-specific gamma interferon response was lower in younger infants and increased with age. As the CD8 T-cell phenotype induced by CMV is indicative of immune dysfunction in the elderly, the existence of a similar phenotype in large numbers of Gambian infants raises the question of whether CMV induces a similarly deleterious effect.
| Year | Citations | |
|---|---|---|
1999 | 5.7K | |
1984 | 4.2K | |
1995 | 1.8K | |
2002 | 1.6K | |
2005 | 1.3K | |
1996 | 1.1K | |
2001 | 1K | |
1995 | 1K | |
2002 | 750 | |
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL Mark R. Wills, A.J. Carmichael, Kim Mynard, HistocompatibilityNormal Virus CarrierMultiple Pp65 PeptidesAutoimmune DiseaseCtl Response | 1996 | 686 |
Page 1
Page 1